Table 3.
Diagnostic accuracy of PDD according to total PSA, grade (Gleason) and stage
| Males with positive biopsy (n=81) | Males with positive PDD (n=60) | Sensitivity | p-value* | |
|---|---|---|---|---|
| 0-4 |
2 |
2 |
100% |
|
| 4-10 |
39 |
28 |
71.8% |
|
| 10-20 |
15 |
11 |
73.3% |
|
| 20- |
25 |
19 |
76.0% |
0.25 |
| Gleason score | ||||
| 6 |
24 |
15 |
62.5% |
|
| 7 |
34 |
26 |
76.4% |
|
| 8-10 |
23 |
19 |
82.6 |
0.11 |
| Clinical stage | ||||
| cT1 |
45 |
34 |
75.6% |
|
| cT2 |
32 |
22 |
68.8% |
|
| cT3 |
4 |
4 |
100% |
|
| cT4 | - | - | - | 0.87 |
*Chi-square test for trend.